PDE5 inhibitors enhance the lethality of [pemetrexed + sorafenib]

類似資料

• PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide
  著者:: Booth, Laurence, 等
  出版事項: (2016)
• PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells
  著者:: Roberts, Jane L, 等
  出版事項: (2014)
• The Lethality of [Pazopanib + HDAC Inhibitors] Is Enhanced by Neratinib
  著者:: Booth, Laurence, 等
  出版事項: (2019)
• [pemetrexed + sildenafil], via autophagy-dependent HDAC downregulation, enhances the immunotherapy response of NSCLC cells
  著者:: Booth, Laurence, 等
  出版事項: (2017)
• Celecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistance
  著者:: Webb, Timothy, 等
  出版事項: (2015)